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My first encounter
with Andreas
Gruentzig was at
the invitation of
Dr. Paul Lichtlen,
then Chief of
Cardiology at
Hannover,
Germany.
I said, “This will
never work in
human atherosclerotic
arteries.” How
(mostly) wrong I was.EDITOR’S PAGE
Short Stories
The wine was particularly good with the seared tuna, arugula, seasonal avocado, and mango
salad. Yes, an occasional dinner at George’s in La Jolla is one of the better perks of this edi-
tor’s job and this evening was special. We were launching a new journal and the editor-in-
chief of JACC: Heart Failure, Chris O’Connor, had joined Tony, me, and the ACC staff for
dinner. The journal will have its first issue out in February, and it promises to be an excellent
publication. Chris was pumping me for tips and tricks of journal editing. I told him that I
would be of limited help because the authors keep sending very good manuscripts, the review-
ers keep improving them, and we, the editors, just pick the best ones. Seems too easy, and
despite taking a great deal of time, it does remain fun. I think he was looking for more sub-
stantive answers, but after all this is election season and perhaps obtuse answers are catching.
In an effort to get something other than platitudes out of me, he asked, “How did Andreas
come to America, and specifically to Emory?” I have heard this question hundreds of times but
coming from such a knowledgeable academic as Chris caused me to launch into a wine-infused
recitation. He said, “You should tell those stories in your Editor’s Page.” I do not know if I
should or not, but realizing that these events took place 32 to 34 years ago, and predated the
literacy of many current cardiologists, I will tell an occasional story from the olden days with
apologies to my actual contemporaries.
My first encounter with Andreas Gruentzig was at the invitation of Dr. Paul Lichtlen, then
Chief of Cardiology at Hannover, Germany. It was the American Heart Association Scientific
Session in Miami Beach in 1976. Professor Lichtlen had stopped briefly at my poster, which I
was narrating, and instead of praising it he said, “You must see a poster in the next aisle. A
fellow from Zurich is proposing to use a balloon to relieve coronary obstruction.” Andreas was
standing in front of the poster illustrating the dog coronary experiment in which a ligature was
tied around the artery producing a stenosis and a measurable resting gradient. After the
balloon inflation, the gradient disappeared. The histology and the other illustrations were, after
all, from a healthy dog artery and I said, “This will never work in human atherosclerotic
arteries.” How (mostly) wrong I was. (As it has turned out, stents have been helpful, but that
is another story.) In less than 1 year, the first patient had undergone percutaneous transluminal
coronary angioplasty (PTCA) and the rush to learn the technique in Zurich was on. A little
over 1 year after that first case was done, I invited Andreas to speak at a small conference
called the South Atlantic Cardiovascular Society. It was a collection of cardiologists and
surgeons with no actual membership who were to assemble at Kiawah Island, South Carolina.
Andreas presented his first cases, and, as was the tradition of the meeting, the antagonist, Dr.
Francis Robicsek, skewered him severely with irony laced with humor. Andreas and his family
met my Emory colleagues, including surgeons, and had a very pleasant time.
Things were not going well in Zurich. Andreas felt inhibited as he was offered only 2 days a
week in the cath lab. Tensions with his superiors were increasing but he continued to conduct
live demonstration courses in Zurich which were attended by most of the earlier adopters from
both sides of the Atlantic. At what I recall was about the third or fourth formal course in
January of 1980, a party was held at a restaurant in the Emmental Valley. I will never forget
the proprietor of the restaurant saying, “I don’t know much about this angioplasty, but its most
important feature is the same as for Swiss cheese. It is not so much the taste or texture that
sets Swiss cheese apart, but those holes. Angioplasty seems to be about creating holes, so I
guess we have something in common.” On the train trip back to Zurich, Andreas sat down
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1000beside me and said he was going to leave Zurich and
would go to Germany or the United States. I asked where
in the United States. He mentioned a few places that had
expressed interest but said that the Cleveland Clinic was
his first choice. I said, “What do you want to do?” He
replied that he felt Cleveland was the center of bypass
surgery and that this would be a fine place to develop and
remain in the forefront of angioplasty. And then he
added, “. . .and I want to be professor.” When I told him
that would not be possible since Cleveland Clinic (at that
time) did not have a medical school, he seemed stunned.
He asked for advice about other places and I suggested
that he come and visit us at Emory. Since he was going
to Aspen the next week to speak at Jack Vogel’s ACC
Snowmass conference, I suggested that afterward he visit
with me for a few days to have a look at our place and to
be introduced to my chief, Willis Hurst. Dr. Hurst was
not amused when I told him what I had done since he
had heard from the chief in Zurich (who had been a
former fellow at Emory) that Andreas was a “prima
donna.” I said that Andreas was staying at my house and
at least he should meet him. His skepticism turned to
enthusiasm after about 10 minutes with Andreas, and Dr.
Hurst became indispensible in the recruitment process.
Andreas had no visa, had not taken any U.S. qualifying
exams, and certainly did not have a license to practice.
We were invited to have lunch in the “Men’s Grill” of
the Piedmont Driving Club (made infamous in Tom
Wolfe’s “A Man in Full”) by Dr. Bruce Logue, Chief of
Cardiology, and Dr. Charles Hatcher, Chief of
Cardiothoracic Surgery. At the next table was Griffin Bell
who had recently served as Attorney General of the
United States. I knew Judge Bell since I was on the board
of trustees of Mercer University and he was Chairman ofthe board. When I introduced Andreas I said I was trying
to recruit him. Judge Bell offered to help if he could. I
replied that his visa might be a problem. He said that he
could not do much about that but his firm was well
suited to pursue those issues. After 6 months and a stack
of legal fees, all hurdles were overcome. Willis Hurst
declared Andreas a “national treasure” on applications,
and somehow in 1980 it worked. There have been rumors
that Andreas was offered vast rewards for coming to
Emory. The Coca-Cola Company was said to have
provided funding. None of that is true. He enjoyed the
faculty with employment conditions similar to the rest of
us. I am sure that the exception that enabled Andreas to
come to the United States would be virtually impossible
today, and it is too bad. The world has become flat and
interventional cardiology is global. It is in the interest of
the specialty and patients worldwide that cross pollination
of ideas and leadership not be unduly restricted. Andreas
Gruentzig’s move to the United States at that time clearly
enabled the development of interventional cardiology that
may have been delayed without it. Today, effective
migratory routes may spur innovation in many different
parts of the world. Many stories about those
developments should be told by those who continue to
move this field forward. This story is one of mine and
others may follow, if Chris O’Connor keeps asking
questions.
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